Back to Search
JOSEPH FIORICA, MD
MD
Student in an Organized Health Care Education/Training Program
NPI: 1053014134Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
Phase II trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study.
PMID 14751131·Gynecol Oncol·2004
3-trial
The role of topotecan in the treatment of advanced cervical cancer.
PMID 13129491·Gynecol Oncol·2003
6-review
Update on the treatment of cervical and uterine carcinoma: focus on topotecan.
PMID 12324632·Oncologist·2002
6-review
Phase II trial of topotecan and cisplatin in persistent or recurrent squamous and nonsquamous carcinomas of the cervix.
PMID 11925125·Gynecol Oncol·2002
3-trial
Subcutaneous management of vertical incisions with 3 or more centimeters of subcutaneous fat.
PMID 16796988·Am J Obstet Gynecol·2006
2-rct
Clinical results and quality of life analysis for the MVAC combination (methotrexate, vinblastine, doxorubicin, and cisplatin) in carcinoma of the uterine cervix: A Gynecologic Oncology Group study.
PMID 16216315·Gynecol Oncol·2006
4-observational
Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study.
PMID 15911865·J Clin Oncol·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 2655 RIDGEWAY AVE STE 220
ROCHESTER, NY 14626 - Phone
- (585) 368-4560
Quick Facts
- NPI
- 1053014134
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile